fbpx

X

Statins May Lower Parkinsonism Risk + New Genetic Test to Prevent Deafness in Babies – Xtalks Life Science Podcast Ep. 56

Statins May Lower Parkinsonism Risk + New Genetic Test to Prevent Deafness in Babies – Xtalks Life Science Podcast Ep. 56

In this episode, Xtalks marked World Parkinson’s Day (April 11) and Parkinson’s Awareness Month, which are observed every year to help raise awareness about the disease and the individuals living with it. To learn more about new Parkinson’s disease research, Ayesha discussed a new study by researchers at Rush University Medical Center that shows statins may help decrease the risk of parkinsonism in older adults. Hear about how parkinsonism relates to Parkinson’s disease and how the neuroprotective effects of statins could prevent Parkinson’s and related conditions.

The editorial team also discussed a new rapid molecular test developed by UK-based Genedrive PLC that can help physicians select the best antibiotic to treat babies with to prevent hearing loss. Gentamicin is the preferred treatment for newborns with infections like sepsis but about one in 500 babies have a genetic variant that makes them susceptible to gentamicin-induced hearing loss. Find out how the new genetic test can produce results in less than half an hour to help clinicians quickly determine the best course of treatment, and its rollout across a couple of NICUs in England.

Listen on Apple Podcasts

Read the full articles here:

Parkinson’s Awareness Month: Statins May Lower Parkinsonism Risk in Older Adults

Genedrive’s Genetic Test Can Prevent Hearing Loss in Babies Through Personalized Treatment

The weekly podcast is available for streaming every Wednesday on SpotifyApple Music and wherever you stream your podcasts.

Subscribe to the Xtalks Life Science Podcast to never miss a new episode.